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Edited by Ulrike KutayAbstract Members of the NIMA-related kinases (NRK) family
are recently emerging as central regulators of various aspects of
the cell cycle. However, the cellular roles of the mammalian
NRK, Nek7, remain obscure. We show here that the endogenous
Nek7 protein is enriched at the centrosome in a microtubule-
independent manner. Overexpression of wt or kinase-defective
Nek7 resulted in cells of rounder appearance, and higher propor-
tions of multinuclear and apoptotic cells. Down-regulation of
Nek7 using a small interfering RNA approach resulted in a sig-
niﬁcant increase in mitotic cells presenting multipolar spindle
phenotype. These results suggest a role for Nek7 in regulating
proper spindle assembly and mitotic progression.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The mammalian NIMA-related kinase (NRK) family consti-
tutes of 11 structurally conserved proteins, denoted Nek1-11
[1]. The founder kinase, never in mitosis, gene A (NIMA),
was originally identiﬁed as a central mitotic regulator in the
ﬁlamentous fungus Aspergillus nidulans. Its documented tasks
include involvement in chromatin condensation (presumably
by phosphorylating histone H3), enabling nuclear entrance
of Cdc2/cyclin B complex into the nucleus, and contribution
to the dramatic reorganization of the microtubule network
seen during mitosis [1,2]. NIMA-like mitotic activities have
recently been ascribed to NRKs from protists, protostomes
and vertebrates suggesting conservation of these pathways.
The members of the Nek6/7 subgroup are the smallest
NRKs, and are consist of a core kinase domain and a short
N-terminal tail [3]. Interestingly, this subfamily is remarkably
conserved, and the kinase domain of the murine Nek6 and
Nek7 are about 76% identical to the C. elegans ortholog.
Nek6 and Nek7 are quite highly similar to each other (87%
identity in the kinase domain), and our analysis suggests that
they are expressed in tissue-speciﬁc complimentary patternsAbbreviations: DN, dominant negative; GFP, green ﬂuorescence pro-
tein; NIMA, never in mitosis, gene A; NRK, NIMA-related kinase;
siRNA, small interfering RNA
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Nek7 has been shown to interact with another Nek kinase, des-
ignated Nercc1/Nek9 [5]. Overexpression of a kinase-dead
Nercc1 construct prohibits cell cycle progression, and injection
of antibodies against Nercc1 results in prometaphase arrest,
abnormal spindle dynamics, chromosomal missegregation
and aneuploidy [5]. It has been recently demonstrated that
activated Nercc1 is recruited to the centrosome during early
mitosis, and that depletion of Nercc1 in Xenopus egg extracts
disrupts the assembly of normal mitotic spindle [6]. Nercc1
phosphorylates Nek6 and Nek7 in vitro, concomitant with in-
crease in their enzymatic activity, and Nek6 levels and kinase
activity were shown to be elevated in mitotic cells [7]. Overex-
pression of inactive Nek6 kinase, or depletion of Nek6 by
small interfering RNA (siRNA), arrested the cells in meta-
phase, and subsequently the cells underwent apoptosis [8].
However, no speciﬁc alteration in microtubule dependent
structures has been noticed.
To gain insight into the cellular functions of Nek7, we ana-
lyzed the subcellular localization of the endogenous Nek7 pro-
tein, and manipulated Nek7 levels in culture cells. Our
observations indicate that Nek7 is a centrosomal kinase, which
regulates proper spindle assembly and mitotic progression.2. Materials and methods
2.1. Generation of polyclonal anti-Nek7 antibodies
A fragment of Nek7 (a.a. 1–146), containing the N-terminal tail and
part of the kinase domain was cloned into pQE expression vector
(Qiagen,Valencia, CA) downstream to the 6XHis tag. Puriﬁed proteins
were injected into rabbits, and the resulting antibodies were aﬃnity-
puriﬁed using the corresponding Nek7 fragment coupled to an acti-
vated cyanogen bromide Sepharose column (Sigma).
2.2. DNA transfections and siRNA tretments
The cloning of HA-tagged Nek7 and Nek6 mammalian expression
vectors has been described before [3]. To create the Ad-HA-Nek7 vec-
tor, the HA-tagged full-length Nek7 sequence was cloned into the SwaI
site of the pAxCAwt adenovirus 5 vector [9], and viruses were pro-
duced in HEK293 cells as described in [9]. HeLa and HEK293 cells
were transiently transfected using the calcium phosphate precipitation
method [10]. The sequence of the siRNA oligos were as follows: Nek7-
siRNA 5 0-GCAACUCAACCAUCCAAAUdTdT-3 0 (283–301 of
mouse nek7, [3]), and the control scrambled-siRNA 5 0-GCACU-
AACCUACCAACAAUdTdT-3 0 (Invitrogen). The Sequence of
Nek7-RNAi inserted into the pSuper vector was 5 0-TGGATGC-
CAAAGCACGTGC-30 (234–252 of mouse nek7), and RNAi against
Luciferase was used as a control. The Nek7 siRNA sequences are also
identical to the human nek7 mRNA. The siRNAs were transfected
using LipofectAMINE 2000 (Invitrogen) according to the manufac-
turer’s protocol. Western blotting using total cell lysates was per-
formed 48 and 72 h post transfection.ation of European Biochemical Societies.
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For immunoﬂuorescence microscopy, cultures grown on coverslips
were ﬁxed in 4% paraformaldehyde for 20 min., blocked with 3% BSA/
0.5% Triton X-100 in PBS, and incubated overnight with primary anti-
bodies at 4 C. Primary antibodies were used as follows: the immunized
anti-Nek7 serum diluted 1:750, Myc-monoclonal antibodies (Zymed
Laboratories, CA) 1:250, HA-monoclonal antibodies (BAbCO, Rich-
mond, CA) 1:1000, and mouse a/b Tubulin (Biomeda, Foster City,
CA) 1:1000. Following washes, the coverslips were incubated with
ﬂuorescein isothiocyanate (FITC)-conjugated anti-mouse and/or Rhod-
amin-conjugated anti-rabbit secondary antibodies (Jackson Immuno-
Research) (1:150). DNA staining was done with propidium–iodide
solution, and the coverslips were mounted on slides with Vectashield
mounting solution (Vector, Burlingame, CA) and sealed. Staining was
analyzed using an MRC 1024 confocal laser microscope (Bio-Rad).
2.4. Centrosome puriﬁcation
Centrosomes were isolated as described by Zhou et al. [11]. Brieﬂy,
exponentially growing HeLa cells were incubated with cytochalasin D
and nocodazole for 1 h. Cells were then washed with 1· PBS, 8% su-
crose in 0.1· PBS, and 8% sucrose in water, and incubated with shak-
ing at 4 C for 10 min in lysis buﬀer. The insolubles were removed by
centrifugation at 2500 · g for 10 min. HEPES was adjusted to 10 mM
and DNase I was added to 2 U/ml. After 30 min, lysates were under-
lain with 60% sucrose solution, and centrosomes were sedimented into
the sucrose cushion by centrifugation at 10000 · g for 30 min. This
crude centrosome preparation was further puriﬁed by discontinuous
sucrose gradient centrifugation at 120000 · g for 1 h. Fractions were
collected from the top, diluted in PIPES buﬀer, and sedimented by cen-
trifugation at 25000 · g for 30 min. Pellet protein was resuspended and
denatured in SDS sample buﬀer.
2.5. Immunoprecipitation and in vitro kinase assay
WT or DN-Nek7 were immunoprecipitated from transfected
HEK293 cells using anti-HA (BAbCO) or anti-Myc (Zymed Laborato-
ries) monoclonal antibody, respectively. The kinase assay was per-
formed according to Yin et al. [8].3. Results
3.1. The endogenous Nek7 protein is enriched at the centrosome
of interphase and mitotic cells
To examine the subcellular localization of Nek7 in mamma-
lian cells, we raised polyclonal antibodies against the N-termi-
nal region of mouse Nek7 protein (a.a. 1–146). The immunized
serum recognized overexpressed Nek7, but not overexpressed
Nek6 protein (Fig. 1A), conﬁrming the speciﬁcity of the
antibodies. Both the immunized anti-Nek7 sera and the aﬃn-
ity-puriﬁed anti-Nek7 antibody speciﬁcally recognize Nek7
protein in Western blot analysis of various mammalian cell
lines (see below, and not shown). Immunocytochemistry stain-
ing of HeLaSS6 cells using the immunized anti-Nek7 serum,
but not the pre-immune serum, revealed enrichment of Nek7
protein at the centrosome of both interphase and mitotic cells
(Fig. 1B). To conﬁrm the centrosomal staining speciﬁcity, the
anti-Nek7 serum was pre-incubated with NEK7 protein. As
can be seen in Fig. 1B, the centrosomal staining was abolished,
while cytoplasmic background staining was still observed.
Nek7 was clearly detected at the spindle poles at all stages of
mitosis, but in contrast to Nercc1/Nek9 [6], it was not associ-
ated with the chromosomes following the metaphase-to-ana-
phase transition, and it was not found in the midbody or
spindle midzone at telophase or cytokinesis stages, respectively
(Fig. 1B). To speciﬁcally decorate the centrosomes, the centri-
olar marker green ﬂuorescence protein (GFP)-centrin 2 [12]
was stably transfected into the HeLaSS6 cell line. Immunocy-
tochemistry staining of these cells demonstrated an overlap be-tween Nek7 and centrin 2 staining. The proximity to the
centrioles suggests that Nek7 is conﬁned to the pericentriolar
region of the centrosome (Fig. 1C).
To examine whether Nek7’s recruitment to the centrosome is
dependent on the microtubule network, HeLaSS6 cells were
treated with 10 lg/ml nocodazole for 15 min, prior to ﬁxation.
Immunocytochemistry staining using anti-a-tubulin antibodies
demonstrated depolymerization of the microtubule network,
and disassembly of the mitotic spindle in dividing cells. Co-
staining of Nek7 and a-tubulin in these cells demonstrated a
centrosomal localization for Nek7, independently of the
microtubule network and mitotic spindle integrity (Fig. 1D).
To further explore the apparent Nek7 localization to the
centrosome, enrichment for centrosomes was carried out using
discontinuous sucrose gradient fractionation [11]. The pooled
fractions were examined for the presence of the centrosome-
associated cytoskeletal protein c-tubulin, and for Nek7. As
can be seen in Fig. 1E high enrichment of c-tubulin was evi-
dent in fractions 6 to 11, and Nek7 enrichment closely paral-
leled that of c-tubulin. As expected, no labeling of the
fractions was observed using the nuclear marker, pRB
(Fig. 1E). Interestingly, while in whole cell extracts Nek7 anti-
bodies mainly stained a protein of about 36 kDa, and very
faintly a band of about 38 kDa (presumably phosphorylated
and activated Nek7 protein, [7]), in the centrosomal-enriched
fractions the higher band was much more prominent, counting
for about 35% of Nek7 protein (Fig. 1E).
3.2. Overexpression of wt or kinase-dead Nek7 in culture cells
results in multinucleated cells
In order to achieve an eﬃcient overexpression ofNek7 protein
in cells, recombinant adenovirus expressing full length Nek7
fused to HA tag was generated according to Miyake et al. [9].
HeLa and NIH3T3 infected cells expressed an HA-tagged
protein of the expected size (Fig. 2I). HeLa cells infected with
Ad-HA-Nek7 had rounder appearance, and bear much smaller
cytoplasmic extensions (Fig. 2II D–F), compared to uninfected
HeLa cells, or to cells infected with adenovirus overexpressing
a b-gal protein (Fig. 2II A–C). There was higher tendency of
the Nek7 infected cells to become multinucleated (1.3% of the
cells compared to 0.6% in the b-gal infected cells; Fig. 2II G–I,
yellow arrow and Fig. 2IV). In addition, by 48 h post infection,
nuclear and cytoskeleton staining revealed a higher proportion
of apoptotic cells (18% of the Nek7 infected cells compared to
3.8% of the b-gal infected cells, Fig. 2II G–H, white arrow;
Fig. 2III). However, it is not clear at this stage whether the apop-
tosiswas directly induced byNek7, or (more plausibly)was a late
response to induction of spindle assembly checkpoint and mito-
tic delay [13].
We next examined the cellular consequences of overexpres-
sion of a kinase defective construct of Nek7 protein. Nek7
kinase activity was abolished by substituting the invariable
glycine residue at the kinase sub-domain I with arginine
(designated Nek7G43R) (Fig. 2V). In similarity to cells over-
expressing Ad-HA-Nek7, multinuclear cells prevail in HeLa
cells transiently overexpressing HA-Nek7G43R. About 12% of
the transfected cells (32 out of 253 cells) had two or more
nuclei, compared to 3.3% of the GFP transfected cells (24
out of 722 cells). In addition, an increase in the percentage
of the apoptotic cells from 4.1% to 7.5% was observed (30
out of 722 of the GFP transfected cells, compared to 19 out
of 253 HA-Nek7G43R transfected cells).
Fig. 1. Nek7 is enriched at the centrosome. (A) Nek7 immunized serum recognized overexpressed Nek7 but not overexpressed Nek6 protein. (B)
Nek7 immunized serum, but not the pre-immune serum, detects Nek7 at the centrosome of interphase, metaphase, anaphase and telophase HeLaSS6
cells. Pre-incubation with NEK7 protein eliminated the centrosomal staining. Red: Chromatin (propidium iodide); Green: Nek7 (C) Co-localization
of Nek7 and GFP-Centrin 2 to the centrosome of HeLaSS6 cells. Red: Nek7; Green: GFP-Centrin 2; Cyan: a/b-Tubulin. (D) Nek7 localization in
HeLaSS6 cells treated with nocodazole. Nek7 localization to the centrosome is not dependent on the microtubule network. (E) Immunoblot analysis
of the fractions from the ﬁnal non-continuous sucrose gradient of the centrosome preparation. The membrane was blotted with aﬃnity puriﬁed anti-
Nek7 antibodies and re-blotted with anti-c-tubulin and anti-retinoblastoma (pRB) antibodies.
N. Yissachar et al. / FEBS Letters 580 (2006) 6489–6495 6491
Fig. 2. Ad-HA-Nek7 overexpression in HeLa cells. (I) HeLa cells were infected with supernatant from infected HEK293 cells diluted as indicated.
HeLa cell extracts were subjected to immunobloting using anti-HA antibodies. (II) Phenotypic analysis of HeLa cells infected with Ad-HA-Nek7.
(A–C) HeLa cells infected with Ad-bGal (as a negative control), showing the normal HeLa cells morphology. (D–I) HeLa cells infected with Ad-HA-
Nek7. The phenotypes include round cells (F), multinuclear cells (yellow arrows in I) and condensed chromatin (white arrows in I). Red: Propidium
iodide DNA staining. Green: Immunostaining using a-Tubulin Ab’s. (III and IV) Apoptotic (III) and multinuclear (IV) cells following Ad-HA-Nek7
overexpression. Data are based on three independent experiments. *P < 0.05, Ad-HA-Nek7 vs. Ad-b Gal. (V) wt or DN-Nek7 were overexpressed,
immuoprecipitated and incubated in vitro in a kinase assay buﬀer containing P32  cATP.
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Fig. 3. Knock-down of Nek7 in HeLaSS6 cells resulted in higher incidence of multinuclear cells and mitotic defects. (A) Nek7 levels following
transfection with Nek7-siRNA or non-speciﬁc control-siRNA, in cells harvested 48 and 72 h post transfection. (B) Statistic analysis of siRNA-Nek7
treated cells exhibiting the indicated phenotypes. Data are based on four independent experiments. *P < 0.05 for both siRNA-Nek7 vs. siRNA-
Scrambled and vs. control. (C–E) Metaphase, anaphase and telophase (respectively), in HeLaSS6 cells transfected with control-siRNA. (F–J)
HeLaSS6 cells transfected with Nek7-siRNA present higher prevalence of multinucleated cells (F, yellow arrow) and abnormal mitotic cells with
multipolar spindle (G–J). Red: Chromatin (propidium iodide); Green: a/b-Tubulin. (K) Nek7 centrosomal staining disappeared following siRNA-
Nek7 treatment. Red: Nek7; Green: GFP-Centrin 2; Cyan: a/b-Tubulin.
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To further investigate the cellular consequences of down reg-
ulation of Nek7 pathway, we reduced Nek7 RNA levels by
employing the siRNA approach. A 19nt siRNA speciﬁc to
Nek7 coding sequence (283–301 in nek7 sequence, [3]) was
chosen to target Nek7, and a scrambled siRNA was used as
a non-speciﬁc control. Transfection of Nek7 siRNA (but not
the control siRNA) into HeLaSS6 cells reduced Nek7 protein
levels to about 10% of those in untreated cells (in cells har-
vested 72 h post transfection, Fig. 3A). In the Nek7-siRNA
treated cells, but not in the scrambled-siRNA treated cells,
the centrosomal staining disappeared, conﬁrming the speciﬁc-
ity of Nek7 centrosomal staining (Fig. 3K).
The Nek7 siRNA treated cells displayed distinct phenotypes:
First, in comparison to the control siRNA transfected cells, a
two fold increase in the mitotic index was observed (Fig. 3B).
This may suggest a mitotic delay or arrest of the cells treated
with Nek7 siRNA. Second, about 7% of the total mitotic cells
displayed multipolar spindle phenotype with three or more
spindle poles (compared with about 1% in the control siRNA
transfected cells) (Fig. 3B). These cells exhibited abnormal
spindle assembly and chromosomes alignment in the meta-
phase stage, and asymmetric chromosomes segregation was
observed in cells proceeding to anaphase (Fig. 3G–J). Similarly
to the wt or DN-Nek7 overexpression phenotype, treatment
with Nek7 siRNA resulted in a three folds increase in the num-
ber of multinucleated cells, compared to the control siRNA
treated cells (Fig. 3B and F). In addition, nuclear and cytoskel-
eton staining revealed a three fold increase in the number of
apoptotic cells (Fig. 3B). Similar results were obtained using
a second RNAi molecule cloned into the pSuper vector, and
targeted against diﬀerent nek7 sequence (not shown).4. Discussion
Multiplication and structural diversiﬁcation of the primor-
dial NRK protein created eleven mammalian Nek kinases. Re-
cently, the centrosome, the basal body and the mitotic spindle
are emerging as the major and most conserved targets of the
NRKs. The current study suggests for the ﬁrst time that mem-
bers of the highly-conserved Nek6/7 NRK subfamily are di-
rectly involved in centrosome functions. Immunoﬂuorescence
staining revealed Nek7 localization to the centrosome through-
out all phases of the cell cycle, suggesting that Nek7 is a resi-
dential centrosomal component. Mammalian and
Dictyostelium Nek2 proteins have also been shown to be per-
manently localized to the centrosome. In contrast, NIMA
and S. pombe Fin1 proteins localization to the spindle pole
body is restricted to mitosis [14,15]. Interestingly, the activated
form of Nek6/7-interacting kinase, Nercc1, is speciﬁcally local-
ized to the centrosome (and spindle poles) only during mitosis
[6]. However, it is not clear, whether cytoplasmic Nercc1 is
phosphorylated in prophase and then recruited to the centro-
some, or alternatively it is a residential centrosomal protein
and is activated during early mitosis [6]. Intriguingly, similarly
to Nercc1, the centrosomal Nek7 fraction is highly enriched
for the phosphorylated (and presumably activated) Nek7
form. As Nercc1 kinase acts upstream of Nek6/7 [7], it is plau-
sible that activation of Nercc1 at the centrosome is followed by
Nek7 phosphorylation.The most prominent phenotype of Nek7-siRNA-transfected
cells is the creation of multipolar spindles. This phenotype
could arise through two diﬀerent major routes: Nek7 could
play a role in the synchronization of the centrosome duplica-
tion cycle with the cell division cycle, for example through par-
ticipation in the cdk2 – nucleophosmin pathway [16–18].
Alternatively, Nek7 could be involved in coordinating cytoki-
nesis. Nek7 deﬁciency will thus results in cytokinesis failure
and accumulation of cells with high centrosome content
accompanied by creation of multipolar spindles. The increased
percentage of multinucleated cells in cells overexpressing DN-
Nek7 or siRNA could support this option. According to this
possibility the higher mitotic index observed in Nek7 siRNA
overexpressing cells is the result of cells stuck late in mitosis.
The similar Nek6 and Nek7 kinases probably duplicated and
diverged during early vertebrate evolution as the zebraﬁsh gen-
ome harbors both Nek6 and Nek7 homologues, while only one
protein exist in the databases of the early chordate, lancelet, and
in echinoderms. It is not clear whether Nek6 and Nek7 retained
similar or overlapping functions or whether they acquired diﬀer-
ent or even opposing functions. Supporting the last option is the
observation that Nek6 and Nek7 respond diﬀerently to serum
deprivation: Nek6 kinase activity falls down, while Nek7 activ-
ity is elevated [19]. In addition, the non-overlapping, tissue-spe-
ciﬁc, patterns of nek6 and nek7mRNAs expression [4] could hint
at diﬀerent functions. Nek6 has been implicated in mitotic con-
trol by the elevation of its kinase activity duringMphase, and by
the requirement for its kinase activity for metaphase to ana-
phase transition [8]. However, no speciﬁc association of Nek6
protein to the centrosome, spindle or kinetochore has been
found [8]. The present study, demonstrating spindle-related phe-
notypes and centrosomal localization of Nek7, could thus sup-
port distinct functions for Nek6 and Nek7.
As is the case for even bona ﬁde centrosomal proteins [20–
22], the centrosomal Nek7 fraction is quite small. It could sug-
gest that Nek7 has additional non-centrosomal functions.
Thus, even though depletion of the centrosomal fraction of
Nek7 is the most probable explanation for the multipolar spin-
dle phenotype of Nek7-siRNA treated cells, additional non-
centrosomal eﬀects should also be taken into account.
The majority of human cancer cells exhibit structural pertur-
bation of the centrosome, supernumerary centrosomes and/or
multipolar spindles. It is widely accepted that supernumerary
centrosomes contribute to the formation of multipolar spindles
and subsequently to defective chromosome segregation and to
aneuploidy [23–25]. Misexpression of several members of the
mitotic kinase families Aurora, Polo and Nek has been con-
nected to centrosome misfunction and to tumorigenesis [26–
28]. Further studies on Nek7 should shed light on the possible
contribution of overexpression or depletion of this kinase to
mammalian oncogenesis.
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